← All stocks

Fortress Biotech, Inc.

FBIO Net buying

CIK 0001429260 #4364 in the set updated 21 Sep 2026

Bought (120 mo)

$10.54M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$702.19K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$702.19K

14 of 14 sales

Net

+$9.84M

+$9.84M against sales at will

By person

12 insiders · 46 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

$8.68M (20)

—

+$8.68M

6,954,507

20.88%

$12.80M

—

WEISS MICHAEL S

Executive Vice Chairman

$1.25M (2)

—

+$1.25M

2,276,562

6.83%

$4.19M

—

Avgerinos George

SVP, BIOLOGICS OPERATIONS

—

$304.50K (4)

−$304.50K

255,170

0.7660%

$469.51K

−1.5%

Hoenlein Malcolm

Director

$300.01K (1)

—

+$300.01K

115,747

0.3475%

$212.97K

—

LOBELL J JAY

Director

$250.00K (1)

—

+$250.00K

192,397

0.5776%

$354.01K

—

Hunter Robyn

Chief Financial Officer

$2.53K (1)

$239.44K (3)

−$236.92K

163,877

0.4920%

$301.53K

−31.3%

Rowinsky Eric K

Director

$10.00K (1)

$127.10K (5)

−$117.10K

68,797

0.2065%

$126.59K

—

Jin David

Chief Financial Officer

$36.55K (3)

—

+$36.55K

1,651,571

4.96%

$3.04M

—

Klein Dov

Director

—

$31.15K (2)

−$31.15K

131,905

0.3960%

$242.71K

—

Lu Lucy

Director

$10.00K (1)

—

+$10.00K

61,273

0.1839%

$112.74K

—

Lorenz Kevin

Director

— (2)

—

$0.00

101,009

0.3032%

$185.86K

—

Harvey Jimmie

Director

—

146,704

0.4404%

$269.94K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 122

Amendments (4/A) skipped 1

Filings about a different issuer 26

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 14

Transactions with no price 0

Shares from compensation/vesting 21,671,630

Sales filed before the plan box existed 13

History held since 16 Sep 2016